Gland Pharma Limited (GLAND) Share Analysis
NSE · Healthcare · Pharmaceuticals
Gland Pharma Limited (NSE: GLAND) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Pharma. As of 21 Sep 2026, the share price was ₹2,962.00, market capitalisation ₹48,875 Cr, P/E 42.7, ROE 10.7%.
Get the AI verdict on GLAND: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
GLAND price and valuation
- Share price
- ₹2,962.00
- Market cap
- ₹48,875 Cr
- P/E ratio
- 42.7
- P/B ratio
- 4.71
- EPS
- ₹68.49
- Book value per share
- ₹629.00
- Dividend yield
- 0.68%
GLAND profitability and growth
- ROE
- 10.7%
- ROCE
- 15.1%
- Debt to equity
- 0.03
- Revenue growth (3 yr)
- 21%
- Revenue growth (5 yr)
- 13%
- Profit growth (3 yr)
- 8%
- Profit growth (5 yr)
- 1%
GLAND 52-week range
- 52-week high
- ₹3,042.00
- 52-week low
- ₹1,573.60
- Face value
- ₹1.00
GLAND shareholding pattern
- Promoters
- 51.77%
- FIIs
- 8.74%
- DIIs
- 30.44%
- Public
- 9.06%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Pharma, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.